The Prognostic Significance of Serum Beta-2 Microglobulin (sβ2m) Levels in Patients with Hodgkin Lymphoma (HL): Final Analysis on 915 Patients Treated with ABVD or Equivalent (ABVDeq) Chemotherapy or Combined Modality Therapy (CT/CMT) Focusing to the Determination of Optimal Cut-Offs
Autor: | Theodoros P. Vassilakopoulos, Maria Panagiota Arapaki, Panagiotis T Diamantopoulos, Maria K. Angelopoulou, Gianpaolo Nadali, Gerasimos Tsourouflis, Maria Moschogiannis, Maria Dimopoulou, Marina Siakantaris, Xanthi Yiakoumis, Flora Kontopidou, Christina H. Kalpadakis, Gabriela Gainaru, John V. Asimakopoulos, Maria Dimou, Sotirios Sachanas, Marie-Christine Kyrtsonis, Panayiotis Tsaftaridis, Eleni Plata, Eleni Variami, Nora-Athina Viniou, Giovanni Pizzolo, Andreas H. Sarris, Kostas Konstantopoulos, Panayiotis Panayiotidis, Gerassimos Pangalis |
---|---|
Rok vydání: | 2022 |
Předmět: | |
Zdroj: | Blood. 140:12016-12017 |
ISSN: | 1528-0020 0006-4971 |
DOI: | 10.1182/blood-2022-169972 |
Databáze: | OpenAIRE |
Externí odkaz: |